Search

7721 results for: ‘museum studies’

  • Presessional FAQs

    ELTU Full-time study FAQ's

  • Blood clots during COVID-19 may be a cause of ongoing cognitive problems

    High levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including ‘brain fog’, giving a major clue as to one cause of their symptoms: blood clots

  • Guidance for arranging and holding viva voce examinations during University shutdown

    During the University shutdown, viva exams should still be held wherever possible. View the University's guide for external examiners.

  • Tony Gershlick

    It is with deep sadness we announce that the University of Leicester and University Hospitals of Leicester NHS Trust (UHL) have lost a talented, dedicated and much loved colleague to COVID-19.

  • Four-midable – Times Uni of the Year shortlisting is Leicester’s fourth accolade in September

    The University of Leicester has been shortlisted for The Times and The Sunday Times University of The Year 2025, the fourth accolade it has received in recent weeks.

  • A tribute to Professor Tony Gershlick

    Professor Anthony (Tony) Gershlick, a Consultant Cardiologist at Glenfield Hospital and Professor of Interventional Cardiology, has died aged 69.

  • Ten University academics appointed to 2021 Research Excellence Framework

    Research England appoint 10 academics from the University of Leicester to serve as panellists in the 2021 Research Excellence Framework (REF).

  • Major investment in doctoral students to support next generation of researchers

    University of Leicester is a partner in two programmes to benefit from £500 million investment in postgraduate training nationally

  • Leicester to lead development of space instrument

    A space mission called SMILE (Solar Wind Magnetosphere Ionosphere Link Explorer) which is a joint collaboration between scientists from the UK, Europe, Canada, the US and China, has received the go-ahead for an initial study phase this summer by the European Space Agency...

  • Weight loss drug hope for patients with type 2 diabetes

    Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10kg, according to a new study published in The Lancet today.

Back to top
MENU